Logo image of BLMN

BLOOMIN' BRANDS INC (BLMN) Stock Fundamental Analysis

NASDAQ:BLMN - Nasdaq - US0942351083 - Common Stock - Currency: USD

7.95  +0.44 (+5.86%)

After market: 7.89 -0.06 (-0.75%)

Fundamental Rating

2

Overall BLMN gets a fundamental rating of 2 out of 10. We evaluated BLMN against 136 industry peers in the Hotels, Restaurants & Leisure industry. BLMN may be in some trouble as it scores bad on both profitability and health. BLMN has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year BLMN was profitable.
BLMN had a positive operating cash flow in the past year.
In multiple years BLMN reported negative net income over the last 5 years.
In the past 5 years BLMN always reported a positive cash flow from operatings.
BLMN Yearly Net Income VS EBIT VS OCF VS FCFBLMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

The Return On Assets of BLMN (-3.78%) is worse than 74.26% of its industry peers.
The Return On Equity of BLMN (-94.47%) is worse than 63.97% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.63%, BLMN is in line with its industry, outperforming 58.82% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BLMN is significantly below the industry average of 15.70%.
Industry RankSector Rank
ROA -3.78%
ROE -94.47%
ROIC 6.63%
ROA(3y)2.17%
ROA(5y)1.65%
ROE(3y)1.18%
ROE(5y)-770.59%
ROIC(3y)9.57%
ROIC(5y)N/A
BLMN Yearly ROA, ROE, ROICBLMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

BLMN has a worse Operating Margin (5.17%) than 63.97% of its industry peers.
In the last couple of years the Operating Margin of BLMN has grown nicely.
BLMN has a Gross Margin of 70.94%. This is amongst the best in the industry. BLMN outperforms 86.76% of its industry peers.
In the last couple of years the Gross Margin of BLMN has remained more or less at the same level.
Industry RankSector Rank
OM 5.17%
PM (TTM) N/A
GM 70.94%
OM growth 3Y-17.88%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.36%
GM growth 5Y0.51%
BLMN Yearly Profit, Operating, Gross MarginsBLMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BLMN is creating some value.
Compared to 1 year ago, BLMN has less shares outstanding
Compared to 5 years ago, BLMN has less shares outstanding
BLMN has a worse debt/assets ratio than last year.
BLMN Yearly Shares OutstandingBLMN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BLMN Yearly Total Debt VS Total AssetsBLMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

BLMN has an Altman-Z score of 0.88. This is a bad value and indicates that BLMN is not financially healthy and even has some risk of bankruptcy.
BLMN has a Altman-Z score of 0.88. This is in the lower half of the industry: BLMN underperforms 70.59% of its industry peers.
The Debt to FCF ratio of BLMN is 140.42, which is on the high side as it means it would take BLMN, 140.42 years of fcf income to pay off all of its debts.
BLMN has a worse Debt to FCF ratio (140.42) than 65.44% of its industry peers.
BLMN has a Debt/Equity ratio of 7.64. This is a high value indicating a heavy dependency on external financing.
BLMN has a worse Debt to Equity ratio (7.64) than 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 7.64
Debt/FCF 140.42
Altman-Z 0.88
ROIC/WACC0.76
WACC8.77%
BLMN Yearly LT Debt VS Equity VS FCFBLMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.34 indicates that BLMN may have some problems paying its short term obligations.
BLMN has a Current ratio of 0.34. This is amonst the worse of the industry: BLMN underperforms 83.82% of its industry peers.
BLMN has a Quick Ratio of 0.34. This is a bad value and indicates that BLMN is not financially healthy enough and could expect problems in meeting its short term obligations.
BLMN has a Quick ratio of 0.26. This is amonst the worse of the industry: BLMN underperforms 88.24% of its industry peers.
Industry RankSector Rank
Current Ratio 0.34
Quick Ratio 0.26
BLMN Yearly Current Assets VS Current LiabilitesBLMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

0

3. Growth

3.1 Past

The earnings per share for BLMN have decreased strongly by -38.14% in the last year.
The Earnings Per Share has been growing slightly by 3.30% on average over the past years.
Looking at the last year, BLMN shows a very negative growth in Revenue. The Revenue has decreased by -15.43% in the last year.
The Revenue has been decreasing by -0.93% on average over the past years.
EPS 1Y (TTM)-38.14%
EPS 3Y-12.64%
EPS 5Y3.3%
EPS Q2Q%-49.33%
Revenue 1Y (TTM)-15.43%
Revenue growth 3Y-1.41%
Revenue growth 5Y-0.93%
Sales Q2Q%-49.97%

3.2 Future

The Earnings Per Share is expected to decrease by -3.59% on average over the next years.
BLMN is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.10% yearly.
EPS Next Y-26.14%
EPS Next 2Y-10.91%
EPS Next 3Y-3.59%
EPS Next 5YN/A
Revenue Next Year-11.86%
Revenue Next 2Y-5.32%
Revenue Next 3Y-3.1%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BLMN Yearly Revenue VS EstimatesBLMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
BLMN Yearly EPS VS EstimatesBLMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 4.42 indicates a rather cheap valuation of BLMN.
Based on the Price/Earnings ratio, BLMN is valued cheaper than 97.79% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.29, BLMN is valued rather cheaply.
A Price/Forward Earnings ratio of 5.98 indicates a rather cheap valuation of BLMN.
BLMN's Price/Forward Earnings ratio is rather cheap when compared to the industry. BLMN is cheaper than 97.06% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.08. BLMN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 4.42
Fwd PE 5.98
BLMN Price Earnings VS Forward Price EarningsBLMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BLMN is valued cheaper than 94.12% of the companies in the same industry.
BLMN's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 91.3
EV/EBITDA 4.33
BLMN Per share dataBLMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

BLMN's earnings are expected to decrease with -3.59% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)1.34
EPS Next 2Y-10.91%
EPS Next 3Y-3.59%

6

5. Dividend

5.1 Amount

BLMN has a Yearly Dividend Yield of 8.67%, which is a nice return.
The stock price of BLMN dropped by -29.58% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
BLMN's Dividend Yield is rather good when compared to the industry average which is at 3.96. BLMN pays more dividend than 96.32% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.57, BLMN pays a better dividend.
Industry RankSector Rank
Dividend Yield 8.67%

5.2 History

On average, the dividend of BLMN grows each year by 19.12%, which is quite nice.
BLMN has paid a dividend for at least 10 years, which is a reliable track record.
BLMN has decreased its dividend in the last 3 years.
Dividend Growth(5Y)19.12%
Div Incr Years1
Div Non Decr Years2
BLMN Yearly Dividends per shareBLMN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

BLMN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-64.5%
EPS Next 2Y-10.91%
EPS Next 3Y-3.59%
BLMN Yearly Income VS Free CF VS DividendBLMN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

BLOOMIN' BRANDS INC

NASDAQ:BLMN (4/17/2025, 8:04:19 PM)

After market: 7.89 -0.06 (-0.75%)

7.95

+0.44 (+5.86%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)02-26 2025-02-26/bmo
Earnings (Next)04-25 2025-04-25/bmo
Inst Owners107.14%
Inst Owner Change0%
Ins Owners1.47%
Ins Owner Change5.36%
Market Cap675.19M
Analysts54.44
Price Target12.01 (51.07%)
Short Float %12.71%
Short Ratio4.5
Dividend
Industry RankSector Rank
Dividend Yield 8.67%
Yearly Dividend0.96
Dividend Growth(5Y)19.12%
DP-64.5%
Div Incr Years1
Div Non Decr Years2
Ex-Date03-11 2025-03-11 (0.15)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.82%
Min EPS beat(2)0.68%
Max EPS beat(2)2.96%
EPS beat(4)2
Avg EPS beat(4)-4.47%
Min EPS beat(4)-13.76%
Max EPS beat(4)2.96%
EPS beat(8)6
Avg EPS beat(8)1.77%
EPS beat(12)10
Avg EPS beat(12)2.87%
EPS beat(16)13
Avg EPS beat(16)11.54%
Revenue beat(2)0
Avg Revenue beat(2)-24.08%
Min Revenue beat(2)-45.88%
Max Revenue beat(2)-2.28%
Revenue beat(4)0
Avg Revenue beat(4)-13.22%
Min Revenue beat(4)-45.88%
Max Revenue beat(4)-2.1%
Revenue beat(8)1
Avg Revenue beat(8)-7.42%
Revenue beat(12)2
Avg Revenue beat(12)-5.51%
Revenue beat(16)4
Avg Revenue beat(16)-4.27%
PT rev (1m)-8.56%
PT rev (3m)-31.06%
EPS NQ rev (1m)0.14%
EPS NQ rev (3m)-15.11%
EPS NY rev (1m)-26.53%
EPS NY rev (3m)-28.36%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.96%
Revenue NY rev (1m)-0.18%
Revenue NY rev (3m)-7.86%
Valuation
Industry RankSector Rank
PE 4.42
Fwd PE 5.98
P/S 0.17
P/FCF 91.3
P/OCF 2.96
P/B 4.98
P/tB N/A
EV/EBITDA 4.33
EPS(TTM)1.8
EY22.64%
EPS(NY)1.33
Fwd EY16.72%
FCF(TTM)0.09
FCFY1.1%
OCF(TTM)2.69
OCFY33.79%
SpS46.51
BVpS1.6
TBVpS-5.97
PEG (NY)N/A
PEG (5Y)1.34
Profitability
Industry RankSector Rank
ROA -3.78%
ROE -94.47%
ROCE 8.39%
ROIC 6.63%
ROICexc 6.83%
ROICexgc 9.37%
OM 5.17%
PM (TTM) N/A
GM 70.94%
FCFM 0.19%
ROA(3y)2.17%
ROA(5y)1.65%
ROE(3y)1.18%
ROE(5y)-770.59%
ROIC(3y)9.57%
ROIC(5y)N/A
ROICexc(3y)9.95%
ROICexc(5y)N/A
ROICexgc(3y)14.55%
ROICexgc(5y)N/A
ROCE(3y)12.12%
ROCE(5y)N/A
ROICexcg growth 3Y-22.71%
ROICexcg growth 5Y1.91%
ROICexc growth 3Y-20.67%
ROICexc growth 5Y2.33%
OM growth 3Y-17.88%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.36%
GM growth 5Y0.51%
F-Score4
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 7.64
Debt/FCF 140.42
Debt/EBITDA 2.73
Cap/Depr 125.72%
Cap/Sales 5.59%
Interest Coverage 3.4
Cash Conversion 60.09%
Profit Quality N/A
Current Ratio 0.34
Quick Ratio 0.26
Altman-Z 0.88
F-Score4
WACC8.77%
ROIC/WACC0.76
Cap/Depr(3y)141.63%
Cap/Depr(5y)109.75%
Cap/Sales(3y)6.11%
Cap/Sales(5y)4.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.14%
EPS 3Y-12.64%
EPS 5Y3.3%
EPS Q2Q%-49.33%
EPS Next Y-26.14%
EPS Next 2Y-10.91%
EPS Next 3Y-3.59%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.43%
Revenue growth 3Y-1.41%
Revenue growth 5Y-0.93%
Sales Q2Q%-49.97%
Revenue Next Year-11.86%
Revenue Next 2Y-5.32%
Revenue Next 3Y-3.1%
Revenue Next 5YN/A
EBIT growth 1Y-44.02%
EBIT growth 3Y-19.03%
EBIT growth 5Y0.67%
EBIT Next Year38.92%
EBIT Next 3Y13.97%
EBIT Next 5YN/A
FCF growth 1Y-96.45%
FCF growth 3Y-70.21%
FCF growth 5Y-45.63%
OCF growth 1Y-57.15%
OCF growth 3Y-17.24%
OCF growth 5Y-6.4%